Aigen Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History

Aigen Investment Management’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-32,521	Closed	-$189K	–	827
2026 Q1	$189K	Buy	32,521 +20,259	+165%	+$134K	0.05%	436
2025 Q4	$96.3K	Sell	12,262 -6,867	-36%	-$54K	0.02%	517
2025 Q3	$156K	Buy	+19,129	New	+$127K	0.02%	704
2025 Q2	–	Sell	-16,769	Closed	-$92.1K	–	1109
2025 Q1	$92.1K	Buy	+16,769	New	+$67.7K	0.01%	696
2023 Q4	–	Sell	-10,384	Closed	-$19.3K	–	1126
2023 Q3	$19.3K	Buy	+10,384	New	+$23.8K	﹤0.01%	784
2022 Q1	–	Sell	-10,586	Closed	-$31K	–	1148
2021 Q4	$31K	Buy	+10,586	New	+$22.9K	﹤0.01%	1018

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Aigen Investment Management's XERS Position: Q2 2026 in Review

Aigen Investment Management sold out of Xeris Biopharma Holdings (XERS) in Q2 2026, closing a stake of 32,521 shares — an estimated $189K sold.

Aigen Investment Management first reported a position in XERS in Q4 2021 and held it in 6 quarters. The position peaked at $189K in Q1 2026. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

Aigen Investment Management reported no remaining Xeris Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
Aigen Investment Management sold 32,521 Xeris Biopharma Holdings shares in Q2 2026, an estimated $189K.
Aigen Investment Management first reported a position in Xeris Biopharma Holdings in Q4 2021 and held it in 6 quarters.
Aigen Investment Management's Xeris Biopharma Holdings position peaked at $189K in Q1 2026.
241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.